BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37535389)

  • 1. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
    Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
    Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
    Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
    Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
    Sharma Y; Patel P; Kurmi BD
    Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
    Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
    J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
    Wang R; Gao Y; Liu A; Zhai G
    J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotherapies for the treatment of ocular diseases.
    Reimondez-Troitiño S; Csaba N; Alonso MJ; de la Fuente M
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):279-93. PubMed ID: 25725262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
    Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
    Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent perspectives for corticosteroids based ophthalmic therapeutics.
    Suresh PK; Sah AK
    Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease.
    Faria MJ; González-Méijome JM; Real Oliveira MECD; Carracedo G; Lúcio M
    Adv Drug Deliv Rev; 2024 Jul; 210():115321. PubMed ID: 38679293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
    Andonova VY
    Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent patents on ocular drug delivery systems.
    Conway BR
    Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of lipid nanoparticles to ocular drug delivery.
    Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
    Mandal A; Bisht R; Rupenthal ID; Mitra AK
    J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-based eye drop: Topical and noninvasive therapy for ocular diseases.
    Wang C; Pang Y
    Adv Drug Deliv Rev; 2023 Mar; 194():114721. PubMed ID: 36773886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent patents and advances in ophthalmic drug delivery.
    Janoria KG; Hariharan S; Dasari CR; Mitra AK
    Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.